TrialsgrambetaRCTs are beautiful
ESC Congress 2026Presentado vie, 28 ago · 12:03 CESTHot Line 1Todos los ensayos Hot Line →

CMR GUIDE

2026

Cardiac Magnetic Resonance GUIDEd Management of Mild-moderate Left Ventricular Systolic Dysfunction

In 353 patients with LVEF 36–50 % and scar on cardiac MRI, a primary-prevention ICD did not reduce sudden cardiac death or haemodynamically significant ventricular arrhythmia compared with an implantable loop recorder.

Resultado

Eficacia: Time to composite of sudden cardiac death or haemodynamically significant ventricular arrhythmia (ventricular arrhythmia producing syncope or hypotension, SBP <90 mmHg)HR 0,76 (IC del 95% 0,37-1,58)

Por debajo de 1 a favor de a primary-prevention ICD, por encima de 1 a favor de an implantable loop recorder.

Tasas de eventos
Diferencia absoluta
1,4 puntos

La diferencia absoluta se deriva de las tasas de eventos.

También se informa: No significant difference. Sudden cardiac death alone 1.7% vs 5.8% (HR 0.26, 95% CI 0.07-0.95). Below 70 years a 72% relative reduction in the primary endpoint, none above.

Publicación original
Subtema
Sudden death prevention
Diseño
Prospective, multicentre, open-label RCT, 1:1 (ICD vs implantable loop recorder), web-based randomisation stratified by site after core-lab LGE-CMR confirmation; recruitment mid-2015 to mid-2022, follow-up at least 3 years; Australia, UK and Europe
Relevancia
Importante: uno de varios pilares.
Fuente
Selvanayagam JB, et al. JAMA. 2026; published online 28 August.doi 10.1001/jama.2026.17078

Discusión y crítica

Scar on CMR does not by itself earn a defibrillator at an ejection fraction of 36-50%: the primary endpoint is neutral and the interval spans a halving and a 58% increase. The isolated reduction in sudden cardiac death and the benefit below 70 years are the interesting part and the fragile part: few events, a secondary endpoint and a subgroup. The comparator was an implantable loop recorder, so the control arm was monitored rather than treated, and recruitment ran from 2015 to 2022 while medical therapy changed underneath the trial.

Comentado en pódcasts